Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells

DW Chan, VWS Liu, LY Leung, KM Yao… - The Journal of …, 2011 - Wiley Online Library
DW Chan, VWS Liu, LY Leung, KM Yao, KKL Chan, ANY Cheung, HYS Ngan
The Journal of pathology, 2011Wiley Online Library
Abstract Aberrant activation of Hedgehog (Hh) signalling has been implicated in the
pathogenesis of human cancers. However, the cognate molecular mechanisms contributing
to this disregulated pathway are incompletely understood. In this study, we showed that Zic2
was frequently over‐expressed and associated with high‐grade cervical cancer (p= 0.032),
high levels of Gli1 (p< 0.001) and CyclinD1 (p< 0.001) by immunohistochemical and
quantitative RT–PCR analyses. Further biochemical studies using luciferase reporter, co …
Abstract
Aberrant activation of Hedgehog (Hh) signalling has been implicated in the pathogenesis of human cancers. However, the cognate molecular mechanisms contributing to this disregulated pathway are incompletely understood. In this study, we showed that Zic2 was frequently over‐expressed and associated with high‐grade cervical cancer (p = 0.032), high levels of Gli1 (p < 0.001) and CyclinD1 (p < 0.001) by immunohistochemical and quantitative RT–PCR analyses. Further biochemical studies using luciferase reporter, co‐immunoprecipitation, subcellular fractionation and immunofluorescence analyses demonstrated that Zic2 can physically interact with Gli1 and retain it in the nucleus, which in turn increases Gli‐mediated transcriptional activity. Gain‐ and loss‐of‐function analyses of Zic2 showed that Zic2 could increase Hh signalling activity, cell proliferation and anchorage‐independent growth ability in cervical cancer cells. Conversely, deletion of the zinc finger domain at C‐terminus of Zic2 significantly abrogated its interaction with Gli1, the retention of Gli1 in the nucleus, effects on Hh signalling activity and oncogenic properties in cervical cancer cells. Our findings suggest that Zic2 is a positive modulator increasing Gli1 transcriptional and oncogenic activity by retaining Gli1 in the nucleus of cervical cancer cells. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Wiley Online Library